Stock LFMD LIFEMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News LifeMD, Inc.

Equities

LFMD

US53216B1044

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
8.31 USD -8.48% Intraday chart for LifeMD, Inc. -32.60% +0.24%
05-09 Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating MT
05-08 Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating
MT
Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (LFMD) LIFEMD Reports Q1 Revenue $44.1M, vs. Street Est of $42.6M
MT
Earnings Flash (LFMD) LIFEMD Posts Q1 EPS $0.01, vs. Street Est of $-0.01
MT
LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance
AQ
LifeMD, Inc. Provides Financial Guidance for the Second Quarter of 2024
CI
LifeMD, Inc. Revises Financial Guidance for the Full Year of 2024
CI
Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)
PR
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
AQ
LifeMD, Inc. Announces A New Strategic Partnership Designed to Revolutionize Weight Management Patient Care
CI
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
AQ
LifeMD, Inc. Appoints Calum Macrae to Its Board of Directors
CI
LifeMD to Report First Quarter 2024 Financial Results on May 8
AQ
BTIG Adjusts LifeMD's Price Target to $14 From $13, Keeps Buy Rating
MT
LifeMD to Participate in Upcoming Investor and Industry Conferences During May
AQ
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
AQ
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
LifeMD : 2024 LifeMD Shareholder Letter
PU
Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating
MT
Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LFMD Stock
  4. News LifeMD, Inc.